Can’t Ignore: Alphatec Holdings (NASDAQ:ATEC), MAG Silver Corp. (NYSEMKT:MVG), MacroGenics (NASDAQ:MGNX), Oramed Pharmaceuticals Inc. (NASDAQ:ORMP), Keryx Biopharmaceuticals Inc. (NASDAQ:KERX)


Alphatec Holdings, Inc. (NASDAQ:ATEC), will release its second quarter 2015 financial results on Tuesday, August 4, 2015, after the close of the market. Alphatec Holdings, Inc. (NASDAQ:ATEC) shares advanced 0.74% in last trading session and ended the day at $1.37. ATEC Gross Margin is 69.30% and its has a return on assets of -3.10%. Alphatec Holdings, Inc. (NASDAQ:ATEC) quarterly performance is -2.84%.

MAG Silver Corp. (NYSEMKT:MVG) ended the last trading day at $6.67. Company weekly volatility is calculated as 6.83% and price to cash ratio as 5.51. MAG Silver Corp. (NYSEMKT:MVG) showed a weekly performance of 5.04%.

On July 14, 2015, MacroGenics, Inc. (NASDAQ:MGNX) entered into an Underwriting Agreement with Morgan Stanley & Co. LLC, Citigroup Global Markets Inc. and Leerink Partners LLC, as representatives of the underwriters named therein (collectively, the “Underwriters”), relating to the public offering (the “Offering”) of 3,525,000 shares of the Company’s common stock, $0.01 par value per share (the “Common Stock”), at a price to the public of $37.00 per share (the “Offering Price”), less underwriting discounts and commissions. On 27 July, MacroGenics, Inc. (NASDAQ:MGNX) shares decreased -3.21% and was closed at $35.54. MacroGenics, Inc. (NASDAQ:MGNX) year to date (YTD) performance is 1.34%.

MLV & Co. restated their buy rating on shares of Oramed Pharmaceuticals (NASDAQ:ORMP) in a report issued on Wednesday, Market Beat.com reports. Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) shares advanced 0.14% in last trading session and ended the day at $6.93. ORMP has a return on assets of -29.30%. Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) quarterly performance is -3.48%.

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential wrongdoing at Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX). Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) caters to the Healthcare space. Its weekly performance is -19.11%. On the last day of trading company shares ended up $7.66. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) distance from 50-day simple moving average (SMA50) is -23.22%.


Leave a Reply

Your email address will not be published. Required fields are marked *